ethidium has been researched along with propentofylline in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernardi, MM; Bondan, EF; Martins, Mde F | 1 |
| Bernardi, MM; Bondan, EF; Martins-Júnior, JL | 1 |
| Bernardi, MM; Bondan, EF; Cardoso, CV; Dossa, PD; Martins, JL; Martins, MF; Viebig, LB | 1 |
3 other study(ies) available for ethidium and propentofylline
| Article | Year |
|---|---|
Propentofylline reverses delayed remyelination in streptozotocin-induced diabetic rats.
Topics: Animals; Astrocytes; Demyelinating Diseases; Diabetes Mellitus, Experimental; Disease Models, Animal; Ethidium; Macrophages; Male; Mesencephalon; Microscopy, Electron, Transmission; Myelin Sheath; Nerve Regeneration; Neuroprotective Agents; Pons; Rats, Wistar; Schwann Cells; Streptozocin; Xanthines | 2015 |
Propentofylline treatment on open field behavior in rats with focal ethidium bromide-induced demyelination in the ventral surface of the brainstem.
Topics: Animals; Brain Stem; Demyelinating Diseases; Ethidium; Exploratory Behavior; Male; Motor Activity; Neuroprotective Agents; Rats; Rats, Wistar; Treatment Outcome; Xanthines | 2016 |
Propentofylline reduces glial scar development following gliotoxic damage in the rat brainstem.
Topics: Animals; Astrocytes; Brain Stem; Demyelinating Diseases; Disease Models, Animal; Ethidium; Glial Fibrillary Acidic Protein; Gliotoxin; Immunohistochemistry; Male; Neuroprotective Agents; Rats, Wistar; Reproducibility of Results; Time Factors; Treatment Outcome; Xanthines | 2016 |